/Resource Pages/Recommended Publications/Recommended Reading/CRISPR-Cas9

Quick Links:

transEDIT CRISPR-Cas9 product overview shERWOOD-UltramiR shRNA product overview MGC premier cDNA product overview MGC premier ORF product overview Yeast knockout collections product overview Mutagenesis, custom cloning, lentiviral packaging, lncRNA knockdown and ssODN templates resources Vector maps and sequences for CRISPR, RNAi and Gene Expression vectors Contact Us about products for your gene analysis and gene editing experiments

Click the tabs below to view a list of peer-reviewed publications citing successful use of transOMIC technologies products.

transEDIT CRISPR-Cas9 resources: Optimized gRNA designs
for efficient gene editing!

Dual-gRNA, Single-gRNA, or All-in-one (gRNA plus Cas9)
lentiviral vector options


Related to CRISPR-Cas9 technology
Read how the authors in this paper used our MEKK3 (MAP3K3) CRISPR and OMNIfect reagent to discover that "silencing of MEKK3 represents a valid approach to revert in vivo the aggressiveness of pancreatic cancer by modulating YAP/TAZ transcriptional activities."

Lentiviral CRISPR-Cas9 Reagents
Read how the researchers below used our inducible CRISPR/Cas9 to "reveal a gatekeeper function of the PPP in a broad range of B cell malignancies that can be efficiently targeted by small molecule inhibition of PP2A and G6PD."...
See how the authors below used our transEDIT CRISPR and Cas9 to interrogate B-lymphoid transcription factors and conclude that " B-lymphoid transcription factors function as metabolic gatekeepers by limiting the amount of cellular ATP to levels that are insufficient for malignant transformation."
See how the authors below used our All-in-One CRISPR to probe the ability of cells to survive stress stimulus.
Read about the development of the CRoatan algorithm used to create the transEDIT-dual library here.
See how the authors of this publication use an approach for showing how “simultaneous mutation of two genes can produce a phenotype that is unexpected in light of each mutation’s individual effect.”
See how the author of this publication used one of our all-in-one vectors to create a TRF null 3T3-L1 stable cell line.